Guide your members to lasting health
Your members are unique. Their care should be, too.
Lightpath draws from Verily’s deep clinical expertise, as well experience in health tech, healthcare regulation, and data science to offer programs delivered from a comprehensive clinical care team, inclusive of medical provider coverage in all 50 states, and AI-enabled support.
Lightpath will provide your plan members more accessible, timely, tailored and engaging care pathways to support better chronic care program adherence, outcomes and costs.
A flexible, multi-tiered solution*
Help more members meet and maintain health goals
Lightpath provides comprehensive and flexible care programs, offering multiple tiers of resourcing based on clinical need. With Lightpath’s intelligent program design, resourcing is purposefully matched, enabling the right care at the right time and maximizing ROI (see the figure and details below), starting with programs to help manage type 1 and type 2 diabetes, prediabetes, weight management, hypertension, and hyperlipidemia.
Metabolic Intensive focuses on members with type 1 diabetes, type 2 diabetes with an A1c > 8% or hypertension with blood pressure > 130/80, inclusive of comorbidities. Members will have access to a dedicated team of licensed experts in metabolic health, nutritional support, behavioral wellness, precision prescribing, and medication adherence as clinically indicated, and paired with AI-enabled support. Plus, medical provider coverage is in all 50 states.
Evidence-based care
Proven chronic care outcomes
Lightpath is an evolution of Verily Onduo virtual care management for chronic conditions, building off its best practices and learnings, and to be reflective of its successes, such as demonstrated outcomes. A peer-reviewed, 4-month study of Verily Onduo with intermittent CGM use in adults with type 2 diabetes showed meaningful glycemic improvements. Improvements in other metabolic health parameters, including weight‡ and blood pressure, were also observed.1
Image: 2.4% A1C decrease in high-risk participants (avg.), 2.4 hours per day increase in time in target blood glucose range (avg.), 4.4 mmHg reduction in systolic blood pressure (total, avg.), 16.6 mg/dL decrease in total cholesterol (avg.) and 9 pound weight loss (avg.). Note: Weight loss results are not guaranteed. Individual weight loss outcomes, amount and time duration will vary.
A smarter, personalized approach*
The right care, at the right time
Members receive tailored nutrition content, nudges and interventions, as well as holistic medication services, including support for GLP-1s and other anti-obesity medications.†
As an evidence-based, learning health system model, Lightpath will continually improve care quality and patient outcomes. With GLP-1 use, the learning platform will inform the right GLP-1 utilization and clinical care for promoting better health and lower costs. This combined with an ongoing, comprehensive care approach and expert clinical team means members can overcome barriers to care for sustainable progress.
Lightpath will dynamically navigate members through our fit-for-member solution as they achieve health outcomes, while optimizing costs and member experience.
